| Date Filed | Type | Description |
| 06/08/2023 |
4
| SKYLER JAY S (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| SKYLER JAY S (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 10,230 options to buy
@ $44.02, valued at
$450.3k
|
|
| 05/27/2020 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed of 2,729 shares
@ $0
Granted 822 shares
@ $0.001, valued at
$0.8
Acquired 2,729 shares
@ $0 |
|
| 01/07/2020 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,700 shares
@ $216.1615, valued at
$583.6k
Sold 5,564 shares
@ $217.3126, valued at
$1.2M
Sold 14,456 shares
@ $218.139, valued at
$3.2M
Sold 3,086 shares
@ $218.9356, valued at
$675.6k
|
|
| 06/04/2019 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed of 3,607 shares
@ $0
Granted 2,729 shares
@ $0.001, valued at
$2.7
Acquired 3,607 shares
@ $0 |
|
| 05/15/2019 |
4
| SKYLER JAY S (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 20,460 options to buy
@ $10, valued at
$204.6k
|
|
| 05/13/2019 |
3
| SKYLER JAY S (Director) has filed a Form 3 on Applied Therapeutics Inc. |
| 02/15/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Exercised 25,806 options to buy
@ $4.58, valued at
$118.2k
|
|
| 06/26/2018 |
4/A
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 3,607 shares
@ $0.001, valued at
$3.6 |
|
| 06/04/2018 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 3,616 shares
@ $0.001, valued at
$3.6 |
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2018 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 31,464 shares
@ $85.1139, valued at
$2.7M
Exercised 31,464 options to buy
@ $7.63, valued at
$240.1k
|
|
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2016 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 25,000 shares
@ $94.0715, valued at
$2.4M
|
|
| 08/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/04/2013 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 11,848 shares
@ $0.001, valued at
$11.8 |
|
| 03/11/2013 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Bought 70,000 shares
@ $15.5, valued at
$1.1M
|
|
| 08/10/2012 |
4
| SKYLER JAY S (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 98,286 shares
@ $31, valued at
$3M
Disposed of 23,000 shares
@ $31, valued at
$713k
Disposed of 201 shares
@ $31, valued at
$6.2k
Disposed of 6,675 shares
@ $31, valued at
$206.9k
Disposed of 20,000 shares
@ $31, valued at
$620k
Disposed of 20,000 options to buy
@ $11.68, valued at
$233.6k
Disposed of 20,000 options to buy
@ $13.18, valued at
$263.6k
Disposed of 12,000 options to buy
@ $16.23, valued at
$194.8k
Disposed of 12,000 options to buy
@ $19.24, valued at
$230.9k
Disposed of 20,000 options to buy
@ $21.52, valued at
$430.4k
Disposed of 12,000 options to buy
@ $22.89, valued at
$274.7k
|
|
| 06/05/2012 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 19,153 shares
@ $0.001, valued at
$19.2 |
|
| 05/17/2012 |
4
| SKYLER JAY S (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 3,000 shares
@ $0
Granted 20,000 options to buy
@ $27.3, valued at
$546k
|
|
| 05/14/2012 |
4
| SKYLER JAY S (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Exercised 8,000 options to buy
@ $9.16, valued at
$73.3k
Exercised 10,000 options to buy
@ $9.4, valued at
$94k
|
|
| 11/22/2011 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Bought 7,000 shares
@ $7.1, valued at
$49.7k
Bought 1,000 shares
@ $7.09, valued at
$7.1k
|
|
| 05/31/2011 |
4
| SKYLER JAY S (Director) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 10,821 shares
@ $0.001, valued at
$10.8 |
|
| 05/25/2011 |
4
| SKYLER JAY S (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 3,000 shares
@ $0
Paid exercise price by delivering 2,510 shares
@ $13.18, valued at
$33.1k
Exercised 3,000 options to buy
@ $11.03, valued at
$33.1k
Granted 20,000 options to buy
@ $13.18, valued at
$263.6k
|
|
|